Evidence map›Paper›PMID 38984758›Full record

ArticleSmall methods2024

Microliter Whole Blood Neutrophil Assay Preserving Physiological Lifespan and Functional Heterogeneity.

Chao Li, Nathan W Hendrikse, Makenna Mai, Mehtab A Farooqui, Zach Argall-Knapp, Jun Sung Kim, Emily A Wheat, Terry Juang

Abstract read
In one paragraph

Article in Small methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chao LiCarbone Cancer Center, University of Wisconsin-Madison, Madison, WI, 53792, USA.ORCID 0000-0002-1126-0655
Nathan W HendrikseDepartment of Integrative Biology, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Makenna MaiDepartment of Molecular and Cell Biology, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Mehtab A FarooquiDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Zach Argall-KnappDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Jun Sung KimDepartment of Molecular and Cell Biology, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Emily A WheatDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Terry JuangDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
ADHESIVE REGULATION DURING CELL MIGRATIONR01CA085862 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher · 2000 to 2026
$7.3M
Under-oil open microfluidic system (UOMS) for studying systemic fungal infectionR01AI154940 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, MCCLEAN, MEGAN N · 2021 to 2025
$3.8M
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase MicrofluidicsR01CA247479 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, LANG, JOSHUA MICHAEL · 2020 to 2024
$3.1M
A multiplexed micro scale assay for real time analysis of pediatric immune cell functionU24AI152177 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, KERR, SHEENA CATHERINE · 2020 to 2024
$1.8M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA085862NCI NIH HHS R01CA085862NCI NIH HHS R01 CA247479NIAID NIH HHS R01 AI154940NIAID NIH HHS U24 AI152177NIBIB NIH HHS R01 EB010039NIH HHS P30CA014520NIH HHS R01AI154940NIH HHS R01CA247479NIH HHS R01EB010039NIH HHS U24AI152177
6 · The paper itself

Abstract

For in vitro neutrophil functional assays, neutrophils are typically isolated from whole blood, having the target cells exposed to an artificial microenvironment with altered kinetics. Isolated neutrophils exhibit limited lifespans of only a few hours ex vivo, significantly shorter than the 3-5 day lifespan of neutrophils in vivo. In addition, due to neutrophils' inherently high sensitivity, neutrophils removed from whole blood exhibit stochastic non-specific activation that contributes to assay variability. Here, a method - named "µ-Blood" - is presented that enables functional neutrophil assays using a microliter of unprocessed whole blood. µ-Blood allows multiple phenotypic readouts of neutrophil function (including cell/nucleus morphology, motility, recruitment, and pathogen control). In µ-Blood, neutrophils show sustained migration and limited non-specific activation kinetics (<0.1% non-specific activation) over 3-6 days. In contrast, neutrophils isolated using traditional methods show increased and divergent activation kinetics (10-70% non-specific activation) in only 3 h. Finally, µ-Blood allows the capture and quantitative comparison of distinct neutrophil functional heterogeneity between healthy donors and cancer patients in response to microbial stimuli with the preserved physiological lifespan over 6 days.

Indexed as

NeutrophilsCell MovementHumansNeutrophil Activationcell migrationneutrophil kineticsnon‐specific activationopen microfluidicswhole blood

Identifiers

PMID38984758
PMCPMC11499044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.